Background: The prognostic significance of the difference between poststress and at rest left ventricular ejection fraction ($LVEF) in patients sent for diagnostic myocardial perfusion study (MPS) is not well characterized. The purpose of this study was to prospectively evaluate the ability of $LVEF in further risk stratifying these patients in addition to the severity/extent of myocardial perfusion abnormalities expressed as the total perfusion deficit at stress (sTPD), according to the type of stress used. Methods and Results: Two-day 99m Tc-MIBI MPS after stress and rest were obtained for 507 patients subdivided according to the type of stress used, sTPD values, and $LVEF. Subsequent cardiac events were determined through a standardized questionnaire applied 1, 2, and 6 years after MPS. Independent of the type of stress used, the 6-year event rate with progressive perfusion and functional abnormalities combined was significant for total events, all-cause death, cardiac death, and revascularization but not for myocardial infarct. When $LVEF decreased by more than j10%, only those individuals with sTPD of 5% or less had increased 6-year total event rates [5.9% vs 15% for those submitted to treadmill test (P G 0.001) and 8.3% vs 19% when submitted to pharmacological stress (P = 0.001)]. An sTPD greater than 5% was the only variable predictive of total events when multivariate analysis was applied (P G 0.001 for treadmill exercise and P = 0.033 for dipyridamole). Conclusions: Estimation of $LVEF in addition to sTPD seems to improve risk stratification for future events when $LVEF decreases by more than j10% for those individuals with normal or near-normal myocardial perfusion (sTPD e 5%). An sTPD greater than 5% was a better prognostic indicator of future events when compared with $LVEF for individuals with greater perfusion abnormality at stress.
T he simultaneous acquisition of myocardial perfusion and left ventricular functional data using gated SPECT (GSPECT) has led to a significant improvement in the diagnostic accuracy for coronary artery disease (CAD) detection, with a resulting improvement in reader confidence. 1Y3 Furthermore, the quantification of multiple perfusion and functional parameters such as the summed scores, 4 total perfusion deficit (TPD), 5Y8 and left ventricular ejection fraction (LVEF) 9 resulted in the definitive acceptance of this imaging technique as a tool for risk stratification and the estimation of incremental prognostic value and the impact of treatment selection on the survival analysis of CAD patients. 10Y21 Publications addressing these issues have focused mainly on the estimation of outcome based on the severity and extent of stressinduced perfusion abnormalities and ventricular functional data, which usually include the establishment of cutoff values for abnormal poststress global LVEF. 10Y21 Although the position statement of the American Society of Nuclear Cardiology on the use of ECG-GSPECT 22 allows for a choice between GSPECT acquisitions at rest or after stress and the consensus statement on reporting of radionuclide myocardial perfusion imaging studies 23 also indicates that the assessment of left ventricular function should be performed with stress and/or rest gated techniques, there is conflicting evidence that both poststress and rest LVEF should be determined for every patient. Johnson et al 24 have demonstrated that ECG-gated data acquired early after stress and at rest may represent a different physiological state, suggesting that poststress functional evaluation may not always reflect true resting measurements and that the full scope of valuable clinical information is achieved by analyzing both poststress and rest global ventricular function. On the other hand, Ramakrishna et al 25 have suggested that, for most patients, poststress LVEF is an accurate reflection of rest LVEF.
Ideally, stress LVEF should be determined during stress or immediately thereafter to obtain the real-time effects of myocardial straining on regional and global myocardial function. However, biodistribution characteristics of myocardial radiotracers such as 99m Tc-MIBI allow for data acquisition between 15 and 60 minutes after tracer injection. 26, 27 This temporal constraint for the evaluation of stressinduced LVEF is partially overcome by the fact that regional wall motion abnormalities may persist for up to 2 hours after completion of exercise stress 28 or dipyridamole testing, 29 when there is postischemic myocardial stunning/hibernation in the absence of necrosis 30 or in the presence of myocardial infarct with or without ischemia. 31 Considering that same-day 99m Tc-MIBI or dual-isotope myocardial perfusion-function study protocols have to deal with variables such as differences in tracer dose, energy, and reconstruction algorithms and that, at present and to our knowledge, there are no available data on the prospective prognostic evaluation of $LVEF for the 2-day 99m Tc-MIBI imaging protocol, the purpose of this investigation was to evaluate the clinical significance of the difference between poststress and rest LVEF compared with the extent and the severity of myocardial perfusion abnormalities expressed by the stress TPD (sTPD) and to risk stratify patients based on $LVEF and according to the type of stress used. approval of the institution's ethics committee. Only 507 patients completed the protocol ( Fig. 1) , having responded to the sixth-year questionnaire and having technically adequate MPS studies. The remaining 332 patients were excluded owing to the lack of response to the sixth-year questionnaire (n = 304), impinging extracardiac radiotracer activity (n = 13), use of a dobutamine protocol (n = 6) and artifacts generated by arrhythmia, noncorrectable patient motion or inadequate left ventricle contouring (n = 9). Demographic, clinical characteristics, and MPS results of the included/excluded patients are described in Table 1 .
Clinical Questionnaire, Endpoints, and Patient Follow-up
A standardized questionnaire was completed for every patient included in the study, containing information about the clinical status of the patient (symptoms, medication in use, and ability to perform routine tasks) and about the occurrence of hard/soft cardiac events (cardiac death, myocardial infarct, and late revascularizationVpercutaneous transluminal coronary angiography and/or coronary artery bypass graft 9 60 days after MPS) and death of any cause. Questionnaires were completed through a telephone interview performed by a researcher blinded to patient MPS data or by mail to those patients not responding. The cause of death was determined by the review of death certificates, the patient's hospital records, and information from close relatives.
Stress Myocardial Perfusion Protocol
Patients were routinely instructed to refrain from consuming food and drugs containing methylxanthines for at least 24 hours. If possible, A-blockers were discontinued for 24 hours before MPS. A symptom-limited or an 85% maximal-load treadmill exercise test was following using the Bruce protocol. For patients unable to walk or on A-blockers, 0.56 mg of dipyridamole per kilogram of body weight [supine or walking on the treadmill with low-level exercise (LLE)] was used as a pharmacological stressor. 99m Tc-MIBI (Lan-theus Medical Imaging, Inc, Billerica, Mass) was injected intravenously with an average dose of 925 MBq (25 mCi) at the maximum treadmill workload, which was kept at that level for at least 2 minutes. For pharmacological testing, the radiotracer was injected at 4 minutes after termination of IV infusion of dipyridamole. When feasible, patients with LBBB as demonstrated in their resting ECG obtained approval from their primary physicians for the use of the vasodilator pharmacological testing protocol, when requested otherwise. End points of exercise stress were severe angina, physical exhaustion, dyspnea, sustained tachyarrhythmia, exertional hypotension, or ischemic ST-T segment depression of at least 0.2 mV and duration of 80 milliseconds. Exercise was considered inadequate if the achieved workload was less than 80% of the predicted maximal heart rate for the particular patient, in the absence of angina or ECG ischemic changes. Result from the dipyridamole vasodilatation stress test in the supine position was considered positive for ischemia if there is occurrence of horizontal or down-sloping ST-segment depression of 1 mm or greater.
GSPECT Data Acquisition and Reconstruction Protocols
All patients were submitted to a 2-day imaging protocol 32 using rest-stress or stress-rest IV injection of 740 to 1295 MBq of 99m Tc-MIBI based on their weight. All image acquisitions were obtained approximately 60 minutes after injection. GSPECT acquisition was obtained for rest and stress studies using a 90-degree dual-detector gamma camera (Vertex Plus ADAC Laboratories, Milpitas, Calif ). A total of 32 frames of 30-second duration using a 64 Â 64 Â 16-pixel matrix (pixel size, 6.33 mm) were obtained with a noncircular orbit for 180 degrees using high-resolution collimators. No attenuation or scatter correction was applied. Standard filtered backprojection was applied for image reconstruction without attenuation or scatter correction. Eight bins per cardiac cycle (100% acceptance window) were obtained for determination of the functional ventricular data 33 using the Cedars-Sinai's software AutoQUANT V. 5.1.1. All studies were reprocessed by 2 of the authors (P.A.C. and P.M.A.) with the updated version AutoQUANT 6.5 for a complete final reading and nonattenuation-corrected TPD determination. 
Image Interpretation and Scintigraphic Indices
Visual interpretation of MPS images was based on short-axis and vertical and horizontal long-axis tomograms. Semiquantitative analysis was obtained with short-axis and vertical long-axis tomograms divided according to the 17-segment model. Summed scores, the extent of perfusion abnormalities, TPD, LVEF, and other functional parameters were determined automatically, without operator interference 5Y8,33,34 [patients with extracardiac activity within the FOV (n = 117), correctable motion during data acquisition (n = 139) were reviewed, confirming noninterference with automatic ventricular wall edge detection]. Patients were subdivided into 8 groups according to the type of stress used (treadmill exercise vs dipyridamole with or without low-level exercise), quantitative myocardial perfusion (normal/near-normal or abnormal myocardial according to sTPD e5% or 95%), and $LVEF (difference between poststress LVEF and rest LVEF ej10% or 9j10%; Table 2 ). The demographic and clinical characteristics of patients included in each group are described in Table 3 , along with MPS perfusion and functional data.
Patients with ischemia with $TPD greater than 2% (poststress TPD j TPD at rest) were compared with nonischemic individuals ($TPD e 2%). When TPD at rest was greater than poststress TPD, $TPD was considered = 0.
Statistical Analysis
Continuous variables are expressed as mean (SD), unless indicated otherwise, as evaluated with Student t test. Statistical differences between categorical variables were analyzed with W 2 test for heterogeneity, and linear-by-linear association with incidence rate was calculated with simple and multiple Poisson regression with robust variances for 95% confidence intervals (CIs). P G 0.05 was considered significant. Relative risk (RR) was estimated in relation to the lowestrisk groups (T1 and D1) with a 95% CI (lower interval value Q1.0 being considered statistically significant). Bonferroni adjustment was applied for the analysis performed (4 patient groups and 5 outcomes), with P e 0.0025 considered significant. All analyses were conducted using SPSS/PASW Version 18.0 (IBM, Somers, NY). 
Treadmill exercise TE1 (n = 170) TE2 (n = 20) TE3 (n = 69) TE4 (n = 24) Dipyridamole D1 (n = 121) D2 (n = 21) D3 (n = 51) D4 (n = 31) j indicates increase in rest/stress LVEF comparison; =, no change between rest and stress LVEF; ,, decrease in rest/stress LVEF comparison (ej10% or 9j10%).
$LVEF indicates the difference between poststress and rest LVEF (poststress LVEF j rest LVEF); sTPD = stress total perfusion deficit. Asymptomatic  23  8  35  19  22  16  33  23  Nonanginal CP  10  9  10  5  12  10  13  13  Atypical angina  54  46  25  43  26  25  25  26  Typical angina  16  38  35  33  43  55  33  48  Medications, %   A-blockers  22  51  15  57  35  59  46  61  Ca 2+ channel A  16  28  25  38  25  27  8  35  Nitrates  16  39  20  48  45  45  42  48  MPS variables  sTPD, median, %  1  2  2  3  11  12  26 $LVEF indicates sLVEF j rLVEF; A, antagonist; CABG, coronary artery bypass graft; CP, chest pain; DM, diabetes mellitus; MPS, myocardial perfusion study; PTCA, percutaneous transluminal coronary angioplasty; rLVEF, rest left ventricular ejection fraction; sLVEF, stress left ventricular ejection fraction; sTPD, stress total perfusion deficit.
RESULTS

Analysis of Event Rates and RR in the Studied Population
Sequential Analysis of sTPD and $LVEF According to the Type of Stress Used Figures 2 and 3 demonstrate that individuals with less prominent perfusion abnormalities (sTPD e 5%) had increased 6-year total event rates when $LVEF decreased more than j10% [5.9% vs 15% for those submitted to treadmill test (P G 0.001) and 8.3% vs 19% when submitted to pharmacological stress (P = 0.001)]. Representing 8.1% of the whole patient cohort (41/507), 76% of these individuals who presented with less perfusion abnormality and increased functional compromise induced by stress did not have a history of previous myocardial infarct and/or revascularization (29/41).
The 6-year event rate with perfusion and functional abnormalities combined was significant for the total events independent of the type of stress applied (P e 0.001) and for all cause death and revascularization but only for those individuals submitted to treadmill testing (P e 0.001). No significant difference was observed for outcomes such as cardiac death or infarct probably because of the relatively small size of the sample population. Little difference in total event rate was verified in those patients with an sTPD greater than 5% when correlated to $LVEF. Figure 2 demonstrates that there was an actual reduction in the total event rate with $LVEF greater than j10% in patients submitted to treadmill exercise, probably because of the elevated incidence of revascularization for those individuals with better global left ventricular function ($LVEF G j10%).
When compared with the lowest-risk individuals in groups TE1 and D1, there was an increased RR of events for all other groups, independent of the type of stress applied ( Figs. 4 and 5 ). Confidence intervals, however, demonstrated statistical significance mostly when there was abnormal myocardial perfusion (sTPD 9 5%). For those individuals with normal or near-normal perfusion with a greater than j10% decrease in $LVEF (groups TE2 and D2), there was a tendency for a significant increase in the RR for total events, with statistical significance only for the occurrence of myocardial infarct in those submitted to pharmacological stress ( Fig. 5 ).
Analysis of $LVEF Independent of sTPD and According to the Type of Stress Used
When comparing groups D1 + D3 ($LVEF j = ,ej10%, n = 172) versus D2 + D4 ($LVEF , 9 j10%, n = 52), the 6-year cu-mulative total event rate was 12.2% and 25%, respectively (P = 0.025) with an RR of 2.0 (CI, 1.1Y3.8). The comparison of groups TE1 + TE3 ($LVEF j = ,ej10%, n = 239) versus TE2 + TE4 ($LVEF , 9 j10%, n = 44) demonstrated a 6-year cumulative total event rate of 12.6% and 20.5%, respectively (P = 0.163) with an RR of 1.6 (CI, 0.8Y3.2; Fig. 6 ).
Analysis of $LVEF Independent of sTPD or the Type of Stress Used
Independent of the stress type or the presence of perfusion abnormalities, there was a significant difference when comparing those individuals with a greater than j10% decrease in $LVEF (n = 96) as opposed to those with an $LVEF j10% or less (n = 411), with a 6-year cumulative total event rate of 22.9% and 12.4%, respectively (P = 0.008) with an RR of 1.85 (CI, 1.2Y2.9) ( Fig. 6 ).
Analysis of sTPD Independent of $LVEF or the Type of Stress Used
Individuals with an sTPD greater than 5% (n = 175) compared with those with an sTPD of 5% or less (n = 332) had a 26.3% total event rate in 6 years as opposed to 8.1% for the group with a lower perfusion abnormality burden (P G 0.001), with an RR of 3.2 (CI, 2.1Y5.0).
FIGURE 2.
Six-year event rate for patients submitted to treadmill testing and according to sTPD and $LVEF combinations detailed in Table 2 . Linear-by-linear association, W 2 : *P G 0.001, **P = 0.001, ***P = 0.005, †P = NS. Six-year event rate for patients submitted to pharmacological stress with dipyridamole and according to sTPD and $LVEF combinations detailed in Table 2 . Linear-by-linear association, W 2 : *P = 0.001, **P = 0.01, ***P = 0.02, †P = NS, ‡P = 0.04. Table 2 ). 
Sequential Analysis of $LVEF and sTPD for Individuals Submitted to Pharmacological Stress
Comparison With Other Perfusion and Functional Variables for the Prediction of Total Events
When using a multivariate analysis of variables that included sTPD greater than 5%, a relative decrease greater than j10% in $LVEF, poststress LVEF less than 45%, and transient ischemic dilation (TID) of 1.2 or higher for the prediction of total events according to the type of stress used (Table 4) , an sTPD greater than 5% was the only significant predictor of total events, independent of the type of stress used (P G 0.001 for treadmill exercise and P = 0.033 for pharmacological testing with dipyridamole). Table 5 summarizes the perfusion and functional parameters in patients with ischemia ($TPD Q 2) compared with nonischemic individuals. $TPD showed a significant correlation with the summed difference score for the analyzed cohort as a whole (n = 507, r = 0.895, P G 0.001). $LVEF was significantly lower in patients with stressinduced ischemia (j3.41% [10.5%] vs j0.07% [12.5%], P = 0.002). Mean poststress LVEF in patients with ischemia was 58.2% (15.3%) versus 61.9% (12.6%) in those without (P = 0.01), although there was no significant difference between patients with/without ischemia for rest LVEF (P = 0.09).
Perfusion and Functional Parameters Analyzed in Patients With Versus Without Ischemia
DISCUSSION
The need to evaluate both poststress and rest LVEF has been deemed necessary in specific situations such as in patients with previous myocardial infarct, 31 for better identification of multivessel CAD with exercise 35 or after adenosine triphosphate loading, 36 and in predicting significant CAD in patients submitted to dipyridamole stress. 37, 38 These studies, however, have all analyzed the difference between poststress and rest LVEF from a diagnostic perspective. There is a paucity of publications addressing the prognostic impact of $LVEF compared with myocardial perfusion and the type of stress used in MPS.
The present study suggests that the use $LVEF may have a broader significance in identifying individuals at a greater risk for cardiac events or death of any cause. Although hindered by a reduced FIGURE 6. Cumulative 6-year total event rate according to $LVEF (ej10% or 9j10%) in all patients and according to the type of stress used. Table 2 ). MI indicates myocardial infarct.
number of patients caused by the subdivision of the studied cohort according to the type of stress applied, when $LVEF was used sequentially after the estimation of the extent and severity of perfusion abnormality at stress expressed by sTPD, individuals with a lower perfusion abnormality burden (sTPD e 5%) were at a greater risk for events when $LVEF decreased by more than j10%, independent of the type of stress applied. Although not quite reaching statistical significance for the RR, probably because of the limited population sampled, it is relevant to be able to further risk stratify patients with a lower sTPD using $LVEF as an adjunct. When analyzing the 6-year event rate according to the type of stress used, there was no significant difference between the groups submitted to dipyridamole or treadmill testing as a whole. However, when $LVEF fell by more than j10%, patients submitted to pharmacological stress had a greater incidence of events when compared with those individuals submitted to dipyridamole + LLE or treadmill testing. This finding would go against the expected lower incidence of ventricular function abnormalities produced by vasodilator stress as opposed to exercise. Because little has been published regarding the added prognostic value of function measurements from 2-day GSPECT with the proposed image acquisition protocol, the present findings would point to the contrary, in agreement with the worse overall clinical status of the population usually submitted to pharmacological stressing.
As expected, individuals with an sTPD greater than 5% were also at a greater risk of events, but when an sTPD greater than 5% was compared with $LVEF, LVEF less than 45%, and TID of 1.2 or higher using multivariate analysis, only a sTPD greater than 5% was predictive of total cumulative 6-year events (P G 0.001 for treadmill exercise and P = 0.033 for dipyridamole). This would imply a relatively greater importance of stress perfusion abnormalities than the actual changes in global poststress/rest LVEF for those individuals with greater perfusion abnormality (sTPD 9 5%). However, it is possible that, for this particular patient cohort sent primarily for diagnostic MPS with a low prevalence of CAD and normal average LVEF, less functional impairment of the left ventricle or the temporal constraint imposed by the used imaging protocol inducing a physiological shift toward normal global left ventricular function may be a factor collaborating with the underestimation of the prognostic capability of $LVEF. It is felt, however, that this finding does not invalidate the fact that patients with a lower perfusion abnormality burden at stress when presenting a greater than 10% decrease of $LVEF may need a more rigorous and aggressive follow-up owing to the suggested increase in the total 6-year event rate. Because only 8% of the studied patient cohort presented with normal/near-normal perfusion accompanied by a significant decrease in $LVEF, future studies will be paramount for the evaluation of the prognostic impact of $LVEF determination in the setting of diagnostic MPS for CAD.
LIMITATIONS
The significant loss of patient follow-up (39.57% of the initial database) is certainly a factor that influenced the obtained results, especially considering that the excluded individuals were ''sicker'' patients. Furthermore, subgrouping of the patient database induced a significant reduction in the number of individuals that constituted each of the different groups when analyzing stress modality, perfusion, and functional characteristics, reducing the statistical power of the analysis. Therefore, other studies are necessary to corroborate the presented results.
Because the acquired MPS were nonYattenuation corrected, a slightly higher value for sTPD cutoff was applied in an attempt to reduce eventual false-positive perfusion abnormalities. A correlation of the present findings with state-of-the-art technology such as a combined quantitative analysis of attenuation-corrected and noncorrected myocardial perfusion SPECT is warranted.
Other potential confounding factors include the fact that small ventricles were not excluded and that other parameters that may influence LVEF determination, such as loading ventricular conditions (blood pressure and heart rate), were not controlled. It should be emphasized that the present results pertain only to the 2-day 99m Tc-MIBI GSPECT protocol with a 1-hour interval between stress/rest and imaging. Although applied in many laboratories, protocols with this timing constraint may induce a selection bias with patients having eventual functional abnormalities improved before imaging was performed.
CONCLUSIONS
The estimation of $LVEF in addition to sTPD showed a tendency toward improving risk stratification for future events when $LVEF decreased by more than j10% for those individuals with normal or near-normal myocardial perfusion (sTPD e 5%). An sTPD greater than 5% was a better prognostic indicator of future events when compared with $LVEF for those individuals with greater perfusion abnormality. Patients submitted to pharmacological stress with supine dipyridamole were at a higher risk when compared with their counterparts submitted to dipyridamole with LLE. 
